Is Almatica Pharma Inc. FDA approved?

Almatica Pharma Inc. holds no registered establishment of its own; 26 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.

What drugs does Almatica Pharma Inc. make?

26 products are listed under Almatica Pharma Inc. in the openFDA NDC Directory, most often as capsule; tablet, film coated; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Almatica Pharma Inc.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 0
Active NDC listings: 24
Labeller names: 2
Live patents: 8
Countries: 0

Catalogue

Drug listings by form and route

24 active NDC listings: 24 human prescription drug. By marketing category: NDA 24.

Dosage form	NDCs
capsule	6
tablet, film coated	5
capsule, extended release	4
capsule, delayed release	3
tablet	3
tablet, film coated, extended release	2
tablet, extended release	1

Route	NDCs
oral	24

Labeller name on the listing	NDCs
almatica pharma llc	21
almatica pharma inc.	3

Exclusivity

Patents and exclusivities

Patent	Product	Covers	Expiry
7776358	VENLAFAXINE BESYLATEvenlafaxine besylate	product	May 2028
8999393	LOREEV XRlorazepam	product	Jan 2034
12721817	DULOXETINE HYDROCHLORIDEduloxetine hydrochloride	product	Jan 2046

Catalogue

Marketed products

Showing 24 of 26.

Brand	Generic name	Form / route	NDC
Duloxetine	Duloxetine	capsule, delayed release, oral	52427-791NDA
Duloxetine	Duloxetine	capsule, delayed release, oral	52427-821NDA
Duloxetine	Duloxetine	capsule, delayed release, oral	52427-913NDA
Gralise	gabapentin	tablet, film coated, oral	52427-803NDA
Gralise	gabapentin	tablet, film coated, oral	52427-804NDA
Gralise	gabapentin	tablet, film coated, oral	52427-806NDA
Gralise	gabapentin	tablet, film coated, oral	52427-850NDA
Gralise	gabapentin	tablet, film coated, oral	52427-890NDA
LOREEV XR	lorazepam	capsule, extended release, oral	52427-658NDA
LOREEV XR	lorazepam	capsule, extended release, oral	52427-661NDA
LOREEV XR	lorazepam	capsule, extended release, oral	52427-663NDA
LOREEV XR	lorazepam	capsule, extended release, oral	52427-667NDA
Macrobid	Nitrofurantoin Monohydrate/Macrocrystalline	capsule, oral	52427-285NDA
Naprelan	Naproxen Sodium	tablet, film coated, extended release, oral	52427-272NDA
Naprelan	Naproxen Sodium	tablet, film coated, extended release, oral	52427-273NDA
Zestoretic	lisinopril and hydrochlorothiazide	tablet, oral	52427-435NDA
Zestoretic	lisinopril and hydrochlorothiazide	tablet, oral	52427-436NDA
Zestoretic	lisinopril and hydrochlorothiazide	tablet, oral	52427-437NDA
citalopram	citalopram	capsule, oral	52427-691NDA
escitalopram	escitalopram	capsule, oral	52427-795NDA
sertraline HCl	sertraline hydrochloride	capsule, oral	52427-664NDA
sertraline HCl	sertraline hydrochloride	capsule, oral	52427-672NDA
venlafaxine	venlafaxine	tablet, extended release, oral	52427-632NDA
zolpidem tartrate	zolpidem tartrate	capsule, oral	52427-775NDA

Compare

Other companies listing gabapentin

Viatris Inc.18 sites · 135 NDC
Sun Pharmaceutical Industries Limited13 sites · 918 NDC
Zydus Lifesciences Limited12 sites · 717 NDC
Strides Pharma Science Limited5 sites · 230 NDC
International Medication Systems, Ltd.3 sites · 2,801 NDC
ScieGen Pharmaceuticals India Private Limited3 sites · 200 NDC
Bryant Ranch Prepack1 site · 4,357 NDC
Proficient Rx LP1 site · 1,729 NDC
RemedyRepack, Inc1 site · 1,521 NDC
NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC

Enquiry

Common questions

Is Almatica Pharma Inc. FDA approved?: Almatica Pharma Inc. holds no registered establishment of its own; 26 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Almatica Pharma Inc. make?: 26 products are listed under Almatica Pharma Inc. in the openFDA NDC Directory, most often as capsule; tablet, film coated; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.